GoKawiilNovartis Halts Eight Trials of Experimental Autoimmune Cell Therapy After Patient Deaths
Novartis suspended eight clinical trials testing a cell therapy for autoimmune and neurological conditions after three participants died in late August. The company has not disclosed the cause of death or which specific therapy is affected beyond confirming the pause across all related studies.